Professor, New Drug Safety Evaluation Center (NDSEC) of Chinese Academy of Medical Sciences & Peking Union Medical College

Dr. Jin is a professor and graduate student supervisor in the New Drug Safety Evaluation Center (NDSEC) of the Chinese Academy of Medical Sciences & Peking Union Medical College, in addition to being Vice General Manager of Beijing Union-Genius Pharmaceutical Technology, Ltd. He mainly engages in drug safety evaluation and studies of the toxicity mechanism and effectiveness of protective drugs against poisoning. He also is committed to the application of alternative methods, such as the use of zebrafish and cell models in pharmacotoxicology. His research focuses on the effect and toxicity of Traditional Chinese Medicine and Natural Products, together with the application of new technologies and methods in pharmacotoxicology, such as Space Mass Spectrometry Imaging technology. Financial support for his research is provided by the National Science and Technology Major Projects, the National Natural Science Fund and Chinese Academy of Medical Sciences-CAMS Innovation Fund. He received the outstanding presentation award for young scientists at the Annual Meeting of China Drug Toxicology in 2012 and the IUTOX 2015 SOT AstraZeneca Award. Dr. Jin is an active member of the Chinese Society of Toxicology.

Doctor, School of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine

Dr. Dong received her PhD in 2011. Her research group studies the pharmacological effects, molecular mechanisms, and related complications of traditional Chinese medicine in the treatment of obesity and diabetes mellitus. Her current interest focuses primarily on adipose tissue plasticity and mitochondrial fission-fusion dynamics in obesity research as well as the identification of novel herbal drugs using such therapeutic strategies. She is a principal investigator or co-investigator of several projects funded by the National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, and others. Dr. Dong has published a series of peer-reviewed research papers in journals such as Diabetology & Metabolic Syndrome, Frontiers in Physiology, etc.

Professor, School of Pharmacy, Shaanxi University of Chinese Medicine

Dr. Wang serves as a Professor of Pharmacology, the Dean of the Graduate School, and the Director of the Discipline Construction Office of Shaanxi University of Chinese Medicine. He is the leader of Pharmacology for the State Administration of Traditional Chinese Medicine, the director of the Chinese Pharmacological Society, a member of the Network Pharmacological Society of Chinese Pharmacological Society, a member of the Chinese Society of Toxicology, and the chairman of the Professional Committee of Chinese Medicine of Shaanxi Pharmacological Society. His main research area is cerebral ischemic injury. He has been involved in research related to key projects and the development of new drugs for the Ministry of Science and Technology and has presided or finished over five projects (two National Natural Science Foundation Projects and three Key Projects of Science and Technology of the Ministry of Education and Shaanxi Provincial Department of Science and Technology). He has published more than 80 papers. He has received six scientific research awards from the Shaanxi Provincial Department of Science and Technology and Department of Education. He was selected as an excellent master graduate of Shaanxi University of Chinese Medicine and received the award of Beijing excellent doctoral thesis. He is a chief engineer of small- and medium-sized enterprises in Shaanxi Province and was named excellent Science Worker in Xianyang City.

Associate Chief Pharmaceutist, Guangxi International Zhuang Medicine Hospital

Dr. Yang is a master tutor at Guangxi University of Chinese Medicine and serves as an evaluation expert for the National Natural Science Foundation of China and as an expert in the evaluation of Guangxi Traditional Chinese Medicine and Ethnic Medicine. He is the Deputy Chief Pharmacist of Guangxi International Zhuang Medical Hospital. He is the reserve subject leader of the National Twelfth Five-Year Key Discipline and Zhuang Medicine Discipline. His main research area is liver fibrosis, including the research and development of traditional Chinese medicine and Zhuang medicine to treat liver fibrosis. His team is devoted to the study of pharmacodynamic substances and the mechanism of action of ethnic medicines, which provides a theoretical basis for the field of anti-liver fibrosis.